Adherence to highly active antiretroviral therapy in a public hospital: an institution based cross-sectional study
DOI:
https://doi.org/10.18203/issn.2454-2156.IntJSciRep20252191Keywords:
Adherence, Highly active antiretroviral therapy, HIV/AIDS, PLWHA, EthiopiaAbstract
Background: The success of human immunodeficiency virus/ acquired immunodeficiency syndrome (HIV/AIDS) treatment relies heavily on patient adherence to antiretroviral therapy (ART). Poor adherence is a leading cause of increased morbidity and mortality among people living with HIV/AIDS (PLWHA). This study examined the factors influencing treatment adherence among PLWHA receiving highly active ART (HAART) at Yekatit 12 hospital in Addis Ababa, Ethiopia.
Methods: A cross-sectional institution-based study was conducted from January to February 2015, involving 200 participants selected through systematic random sampling. Data were collected using an interviewer-administered questionnaire, entered into spreadsheet software, and analyzed using IBM® SPSS® statistics version 25. Correlation analysis was used to evaluate participants' perceptions of the impact of ART category on adherence.
Results: The mean age of the respondents was 35.9±5.9 years. The overall proportion of adherent people was 74.4±1.2%. "Being busy" (19.5%), "forgetfulness" (17.5%), and "I did not want others to notice the medication use" (9%) were the most common reasons given by participants. The percentage of adherence to ART was correlated with ART acceptability and availability. ART acceptability correlation was statistically significant; [r (200)=-0.96, p=0.03]. However, the ART availability correlation was insignificant; [r (200)=-0.061, p=0.3].
Conclusions: In summary, according to the WHO ART adherence standard, the average adherence level in this study was classified as poor. Enhancing adherence to ART necessitates implementing targeted adherence strategies, fostering strong patient–provider relationships, and promoting the use of memory aids.
Metrics
References
Larry Buhl. Aging and HIV: Clinician-Patient Connection Guide. 2022. Available at: https://www.thebodypro.com/article/adapting-patient-care-aging-hiv-population. Accessed on 12 April 2025.
UNAIDS. UNAIDS Global and Regional Data. 2021. Available at: https://www.unaids.org/ sites/default/files/media_asset/JC3032_AIDS_Data_book_2021_En.pdf. Accessed on 12 April 2025.
EPHI. HIV Related Estimats and Projections in Ethiopia for the Year-2020. 2021.
Wasti SP, van Teijlingen E, Simkhada P, Randall J, Baxter S, Kirkpatrick P, et al. Factors influencing adherence to antiretroviral treatment in Asian developing countries: a systematic review. Trop Med Int Health. 2012;17(1):71-81. DOI: https://doi.org/10.1111/j.1365-3156.2011.02888.x
Iacob SA, Iacob DG, Jugulete G. Improving the Adherence to Antiretroviral Therapy, a Difficult but Essential Task for a Successful HIV Treatment-Clinical Points of View and Practical Considerations. Front Pharmacol. 2017;8:831. DOI: https://doi.org/10.3389/fphar.2017.00831
Nachega JB, Vincent CM, van Zyl GU, Gardner EM, Preiser W, Hong SY, et al. HIV treatment adherence, drug resistance, virologic failure: evolving concepts. Infect. Disord Drug Targets. 2011;11(2):167-74.
Mbuagbaw L, Lehana T, Ongolo-Zogo P, Yondo D, Noorduyn S, Smieja M, et al. Trends and determining factors associated with adherence to antiretroviral therapy (ART) in Cameroon: a systematic review and analysis of the CAMPS trial. AIDS Res Ther. 2012;9(1):37. DOI: https://doi.org/10.1186/1742-6405-9-37
Nachega JB, Marconi VC, van Zyl GU, Gardner EM, Preiser W, Hong SY, et al. HIV Treatment Adherence, Drug Resistance, Virologic Failure: Evolving Concepts. Infect Disord Drug Targets. 2011;11(2):167-74. DOI: https://doi.org/10.2174/187152611795589663
Hansana V, Sanchaisuriya P, Durham J, Sychareun V, Chaleunvong K, Boonyaleepun S, et al. Adherence to Antiretroviral Therapy (ART) among People Living with HIV (PLHIV): a cross-sectional survey to measure in Lao PDR. BMC Public Health. 2013;13:617. DOI: https://doi.org/10.1186/1471-2458-13-617
Achappa B, Madi D, Bhaskaran U, Ramapuram JT, Rao S, Mahalingam S. Adherence to Antiretroviral Therapy Among People Living with HIV. No Am J Med Sci. 2013;5(3):220. DOI: https://doi.org/10.4103/1947-2714.109196
Azia IN, Mukumbang FC, Wyk B. Barriers to adherence to antiretroviral treatment in a regional hospital in Vredenburg, Western Cape, South Africa. South Afr J HIV Med. 2016;17(1):476. DOI: https://doi.org/10.4102/sajhivmed.v17i1.476
Gebreagziabher TT, Woldemariam GT. Antiretroviral Treatment Adherence and Determinant Factors Among Adult People Infected with Human Immunodeficiency Virus in Eastern Tigray General Hospitals, Northern Ethiopia, 2019. HIVAIDS Auckl NZ. 2020;12:497-505. DOI: https://doi.org/10.2147/HIV.S273917
OARAC. HIV/AIDS Treatment Guidelines. Clinicalinfo.HIV.gov. Available at: https://clinicalinfo.hiv.gov/en/guidelines. Accessed on 15 April 2025.
Shoko C, Chikobvu D. A superiority of viral load over CD4 cell count when predicting mortality in HIV patients on therapy. BMC Infect Dis. 2019;19:169. DOI: https://doi.org/10.1186/s12879-019-3781-1
Monjok E, Smesny A, Okokon IB, Mgbere O, Essien EJ. Adherence to antiretroviral therapy in Nigeria: an overview of research studies and implications for policy and practice. HIVAIDS Auckl NZ. 2010;2:69-76. DOI: https://doi.org/10.2147/HIV.S9280
Hinkin CH, Hardy DJ, Mason KI, Castellon SA, Durvasula RS, et al. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS Lond Engl. 2004;18(1):S19-25. DOI: https://doi.org/10.1097/00002030-200401001-00004
Golin CE, Liu H, Hays RD, Miller LG, Beck CK, Ickovics J, et al. A Prospective Study of Predictors of Adherence to Combination Antiretroviral Medication. J Gen Intern Med. 2002;17(10):756-65. DOI: https://doi.org/10.1046/j.1525-1497.2002.11214.x
Orrell C, Bangsberg DR, Badri M, Wood R. Adherence is not a barrier to successful antiretroviral therapy in South Africa. AIDS. 2003;17(9):1369-75. DOI: https://doi.org/10.1097/00002030-200306130-00011
Gebrezgabher BB, Kebede Y, Kindie M, Tetemke D, Abay M, Gelaw YA. Determinants to antiretroviral treatment non-adherence among adult HIV/AIDS patients in northern Ethiopia. AIDS Res Ther. 2017;14:16. DOI: https://doi.org/10.1186/s12981-017-0143-1
Byakika-Tusiime J, Oyugi JH, Tumwikirize WA, Katabira ET, Mugyenyi PN, Bangsberg DR. Adherence to HIV antiretroviral therapy in HIV+ Ugandan patients purchasing therapy. Int J STD AIDS. 2005;16(1):38-41. DOI: https://doi.org/10.1258/0956462052932548
Kleeberger CA, Phair JP, Strathdee SA, Detels R, Kingsley L, Jacobson LP. Determinants of Heterogeneous Adherence to HIV-Antiretroviral Therapies in the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr. 2001;26(1):82-92. DOI: https://doi.org/10.1097/00042560-200101010-00012
Mengesha MM, Teshome A, Ajema D, Tura AK, Hallström IK, Jerene D, et al. The association between HIV diagnosis disclosure and adherence to anti-retroviral therapy among adolescents living with HIV in Sub-Saharan Africa: A systematic review and meta-analysis. PLOS ONE. 2023;18(5):e0285571. DOI: https://doi.org/10.1371/journal.pone.0285571
Mi T, Li X, Zhou G, Qiao S, Shen Z, Zhou Y, et al. HIV Disclosure to Family Members and Medication Adherence: Role of Social Support and Self-efficacy. AIDS Behav. 2020;24(1):45-54. DOI: https://doi.org/10.1007/s10461-019-02456-1
Mitiku H, Abdosh T, Teklemariam Z. Factors Affecting Adherence to Antiretroviral Treatment in Harari National Regional State, Eastern Ethiopia. ISRN AIDS. 2013;2013:e960954. DOI: https://doi.org/10.1155/2013/960954
Stirratt MJ, Remien RH, Smith A, Copeland OQ, Dolezal C, Krieger D; SMART Couples Study Team. The Role of HIV Serostatus Disclosure in Antiretroviral Medication Adherence. AIDS Behav. 2006;10(5):483-93. DOI: https://doi.org/10.1007/s10461-006-9106-6
Ramadhani HO, Muiruri C, Maro VP, Omondi M, Mushi JB, Lirhunde ES, et al. Association of knowledge on ART line of treatment, scarcity of treatment options and adherence. BMC Health Serv Res. 2016;16:265. DOI: https://doi.org/10.1186/s12913-016-1483-6
Bitew BD, Berehane Y, Getahun EA, Abyu DM. Determinants of None-Adherence to Antiretroviral Therapy among HIV-Infected Adults in Arba Minch General Hospital, Gamo Gofa Zone, Southern Ethiopia: A Case Control Study. Am J Health Res. 2014;2:234. DOI: https://doi.org/10.11648/j.ajhr.20140205.13
Li MJ, Murray JK, Suwanteerangkul J, Wiwatanadate P. Stigma, Social Support, And Treatment Adherence Among Hiv-Positive Patients In Chiang Mai, Thailand. Aids Educ Prev Off Publ Int Soc AIDS Educ. 2014;26(5):471-83. DOI: https://doi.org/10.1521/aeap.2014.26.5.471
Heestermans T, Browne JL, Aitken SC, Vervoort SC, Klipstein-Grobusch K. Determinants of adherence to antiretroviral therapy among HIV-positive adults in sub-Saharan Africa: a systematic review. BMJ Glob Health. 2016;1(4):e000125. DOI: https://doi.org/10.1136/bmjgh-2016-000125
Senkomago V, Guwatudde D, Breda M, Khoshnood K. Barriers to antiretroviral adherence in HIV-positive patients receiving free medication in Kayunga, Uganda. AIDS Care. 2011;23(10):1246-53. DOI: https://doi.org/10.1080/09540121.2011.564112
Downloads
Published
How to Cite
Issue
Section
